SYDNEY, AAP – Market giant CSL has helped offset losses on the Australian share market after investors liked the biotech’s earnings forecast.

CSL boss Paul Perrault said he expected a full-year net profit of up to $US2.25 billion (about $3 billion) given troubles collecting blood plasma during the pandemic.

Shares were up 1.8 per cent to $292.68.

The rest of the market was mostly lower and the biggest falls were in technology and energy.

The benchmark S&P/ASX200 index closed lower by 19.1 points, or 0.26 per cent, to 7280.7.

The All Ordinaries closed down 25.5 points, or 0.34 per cent, to 7575.6.

The Australian dollar was buying 73.54 US cents at 1623 AEDT, higher from 73.18 US cents at Monday’s close.